Palisade Bio, Inc.

PALI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001357459

SEC filings (opens in a new tab)

In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Palisade Bio, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of PALI: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	86	1	96	+11
Shares	135.9M	2.12M	149.5M	+15.7M (+11.8%)
Value	$319.4M	$4.97M	$261.7M	−$52.7M (−16.8%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Palisade Bio, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to PALI in Q1 2026
Institution	Shares	Value	% of portfolio
Great Point Partners LLC	3,405,757	$5.96M	1.46%
Federated Hermes, Inc.	3,136,607	$5.49M	0.01%
Wellington Management Group LLP	2,904,911	$5.08M	0.00%
Marshall Wace, LLP	2,754,403	$4.82M	0.01%
Vestal Point Capital, LP	2,500,000	$4.38M	0.12%
Vanguard Capital Management LLC	1,429,308	$2.50M	0.00%
Propel Bio Management, LLC	1,115,000	$2.00M	1.26%
Standard Life Aberdeen plc	662,900	$1.16M	0.00%
Vanguard Fiduciary Trust Co	659,289	$1.15M	0.00%
Simplify Asset Management Inc.	350,000	$612.5K	0.01%
Landscape Capital Management, L.L.C.	325,019	$568.8K	0.04%
Brevan Howard Capital Management LP	214,821	$375.9K	0.00%
HRT Financial LP	211,882	$370.0K	0.00%
BNP Paribas Arbitrage, SA	189,261	$331.2K	0.00%
Qube Research & Technologies Ltd	148,970	$260.7K	0.00%
Prelude Capital Management, LLC	133,131	$233.0K	0.02%
Graham Capital Management, L.P.	105,832	$185.2K	0.01%
Sectoral Asset Management Inc	88,000	$172.4K	0.14%
EntryPoint Capital, LLC	79,495	$139.1K	0.04%
Charles Schwab Investment Management Inc	76,000	$133.0K	0.00%
Vanguard Global Advisers, LLC	52,292	$91.5K	0.00%
Diametric Capital, LP	51,874	$90.8K	0.02%
Gsa Capital Partners LLP	43,730	$77.0K	0.00%
Catalyst Funds Management Pty Ltd	31,400	$55.0K	0.01%
CTC Alternative Strategies, Ltd.	17,441	$30.5K	0.07%
RSM US Wealth Management LLC	15,743	$27.6K	0.00%
LMR Partners LLP	15,400	$26.9K	0.00%
Jump Financial, LLC	15,346	$26.9K	0.00%
ExodusPoint Capital Management, LP	13,125	$23.0K	0.00%
RFG Advisory, LLC	11,750	$20.6K	0.00%
Quantbot Technologies LP	381	$667	0.00%

Sold out (20)

Institutions that held Palisade Bio, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of PALI in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
StemPoint Capital LP	4,192,375	$9.85M
Vivo Capital, LLC	2,293,578	$5.39M
Price T Rowe Associates Inc	1,577,856	$3.71M
Resolute Capital Asset Partners LLC	400,000	$940.0K
Superstring Capital Management LP	367,103	$862.7K
Quadrature Capital Ltd	240,586	$565.4K
Susquehanna International Group, LLP	212,659	$499.7K
Scientech Research LLC	211,441	$496.9K
TD Asset Management Inc	204,448	$480.5K
Diadema Partners LP	166,049	$390.2K
Manufacturers Life Insurance Company, The	106,636	$251.7K
Silverarc Capital Management, LLC	102,108	$240.0K
Virtus ETF Advisers LLC	46,000	$108.1K
Lighthouse Investment Partners, LLC	39,480	$92.8K
Atom Investors LP	14,041	$33.0K
Virtu Financial LLC	11,870	$28.0K
Federation des caisses Desjardins du Quebec	100	$235
SHP Wealth Management	50	$118
Wells Fargo & Company	21	$49
FMR LLC	10	$24

Not filed for Q1 2026 yet (1)

Institutions that held Palisade Bio, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PALI in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	2,115,622	$4.97M